1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  

This page is powered by Blogger. Isn't yours?

Tuesday, December 27, 2016

 

New Drugs Restore Memory Loss And Prolong Life, Show Promise As Alzheimer’s Disease Treatment: VIDEO





























Researchers at University of Leicester discovered a drug for Alzheimer’s disease that not only improves the neurodegenerative symptoms but also extends the life span of terminally ill mice. The novel drug-like molecules that improved degenerating brain cells in mice has the potential to treat AD in humans.  (University of Leicester)

A team of scientists at the University of Leicester have discovered a drug for Alzheimer's disease that not only improves the neurodegenerative symptoms but also extends the life span of terminally ill mice.

The team of international researchers based at the Medical Research Council Toxicology Unit in UL conducted a four-year study in mice to find a new drug that targets a particular protein in the brain of Alzheimer's disease patients.

New Drug For Alzheimer's Disease

The study deals with discovery of a novel drug-like molecules that help in retrieving the loss of memory and slowing down the degeneration of brain in mice. It has the potential to treat AD in humans, said Andrew Tobin, the corresponding author of the study, and Dr. Sophie Bradley, the lead researcher of the study.

For the purpose of the study, the investigators used mice with degenerating brain cells that mimic the brain of humans with AD. The researchers concentrated on a protein that is previously known to be associated with AD, which they believed could be a potential drug target.

It was observed that when terminally ill mice were treated with novel drugs that are aimed at the specific protein in the brain, the animals not only exhibited improvement in neurodegenerative symptoms but also had an extended life span.

Protein Target For The Treatment Of Alzheimer's Disease

A number of studies conducted earlier used a variety of drugs that targeted the particular protein in brain and found that in spite of providing improvements in cognitive functions, they also resulted in severe side effects.

In contrast, the drug named allosteric ligands that is used in the current study did not result in any adverse effect on mice when they attacked M1 muscarinic receptor, the target protein in the brain. When the above receptor in the brain is activated by the drug, the mice showed great improvement in cognitive functions, symptoms of brain degeneration, and life span.

Development Of Viable Drug Target

The study findings are of great value in understanding whether M1 muscarinic receptor is a "viable drug target" for developing reliable treatment options against AD. As a matter of fact, there are no effective treatments for the debilitating dementia, as all the intervention methods available in the market are aimed at masking the symptoms of the disease.


Story Source: The above story is based on materials provided by TECHTIMES
Note: Materials may be edited for content and length

Labels: